Intensity Therapeutics, Inc. (INTS) Misses Q1 EPS by 4c

Intensity Therapeutics, Inc. (NASDAQ: INTS) reported Q1 EPS of ($0.22), $0.04 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.

You May Also Be Interested In

• Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
• Marvell signs major custom silicon deal with Google, sell-side comments
• Lowe's slashes full-year sales outlook amid DIY spending pressure